跳至主要内容
临床试验/JPRN-jRCT1061220067
JPRN-jRCT1061220067招募中2 期

Fracture prevention using selective estrogen receptor modulatorin patients with osteoporosis who received radiation therapy for cervical cancer - Frap-SERM

agao Shoji0 个研究点目标入组 80 人开始时间: 2022年11月4日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • Patients who meet all of the following criteria will be considered.
  • Patients with histologically confirmed cervical cancer.
  • Patients who are scheduled to receive radical radiotherapy, including concomitant intracavitary irradiation, as initial treatment for cervical cancer.
  • Postmenopausal patients ,menstrual amenorrhea for at least twelve months prior to the start of radiotherapy.
  • Patients who have given written consent to participate in the study.

排除标准

  • Patients who are expected to have difficulty completing the study or subsequent follow-up, or who are deemed unsuitable by their physicians.

研究者

发起方
agao Shoji

相似试验